Le Lézard
Classified in: Health

Dalton Pharma Services Continues to Be Recognized, for the Fourth Consecutive Year, As a Great Place to Work in Canada, 2018


TORONTO, Oct. 11, 2018 /PRNewswire-PRWeb/ -- Dalton Pharma Services is excited to announce once again, that we have been re-certified, for a 4th year in a row, as a Great Place to Work® after a comprehensive independent analysis conducted by Great Place to Work® Institute Canada. This certification is based on direct feedback from employees, provided as part of an anonymous survey about the workplace experience.

Dalton`s certification as a Great Workplace shows its commitment towards providing a culture of inclusion, diversity, fulfillment & respectful work environment. This has played a major role in attracting and retaining talented people from around the world and creating a vibrant & award-winning workplace.

"We`re proud of our legacy as a Great Place to Work and believe that people are a company`s biggest asset. Dalton continually invests in ensuring a welcoming & dynamic work environment and our success truly depends on the passion and ability of our people to deliver unmatched value to our clients," said Mr. Peter Pekos, our CEO.

Earlier this year, Dalton was also recognized as the Top 50 Best Workplacestm in Canada in 2018. Dalton also continued its longstanding tradition of being a leader in the CMO industry by receiving the CMO Leadership Award, 2018 for its Expertise, Quality & Reliability, for a third year in the row.

About Dalton Pharma Services:
Dalton Pharma Services is a leading North American cGMP pharmaceutical organization providing integrated drug discovery, development and manufacturing services. We are FDA registered and Health Canada approved and bring over 30 years of experience to every project. We deliver fully integrated solutions with an emphasis on speed, flexibility and quality. Our integrated services (drug discovery, formulation and process development, custom synthesis, cGMP sterile fill/finish of liquids and powders, cGMP API manufacturing and/or dosage form manufacturing and Accelerated Stability Testing) all at one location helps us to be adaptable, flexible and cost-effective.

To learn more about our history and capabilities, please visit http://www.dalton.com.

About Great Place to Work:
GPTW (http://www.greatplacetowork.ca) is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, GPTW recognizes the world's Best Workplaces in a series of national lists including those published by Fortune magazine (USA) and The Globe & Mail (Canada). Great Place to Work® provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures.

Follow GPTW online at http://www.greatplacetowork.ca and on Twitter at @GPTW_Canada.

Peter Pekos
CEO
Dalton Pharma Services
349 Wildcat Road
Toronto, Ontario
Tel: 416-661-2102

 

SOURCE Dalton Pharma Services


These press releases may also interest you

at 17:00
MosquitoMate, Inc., a leader in innovative mosquito control solutions, today announced that the United States Environmental Protection Agency (EPA) has granted registration for its revolutionary new product named "WB1 Males." This new mosquito...

at 17:00
Leading family safety and location app Life360, has today announced the rollout of new safety features and enhancements through a triple-tier membership structure, offering a spectrum of benefits. With 2 million Aussies already benefiting from the...

at 16:55
The Registered Nurses' Association of Ontario (RNAO) is welcoming 17 new health organizations to its world-renowned Best Practice Spotlight Organization® (BPSO®) program. These organizations, spanning all health-care sectors, join RNAO in its mission...

at 16:54
Dr. Ryan M. Jouett, DDS, LVIM, FICOI has become one of only 25 Master Dentists in the world as a graduate of the Las Vegas Institute for Advanced Dental Studies in Las Vegas, NV....

at 16:48
Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of substantially all of the assets of Endo International plc ("EIP"), as contemplated under EIP's...

at 16:45
Solventum announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. The earnings press release and accompanying materials will be available on the company's website at...



News published on and distributed by: